14 results for author:"Rao D.S." in Literature citations
Results Customize
› Repeat search in UniProtKB (12)
| Role of CYP1A1 haplotypes in modulating susceptibility to coronary artery disease. Lakshmi S.V., Naushad S.M., Saumya K., Rao D.S., Kutala V.K. Indian J. Biochem. Biophys. 49:349-355(2012) · Mapped (10) |
| Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Hur E.M., Patel S.N., Shimizu S., Rao D.S., Gnanapragasam P.N., An D.S., Yang L., Baltimore D. Blood 120:4571-4582(2012) · Mapped (1) |
| Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Bhadada S.K., Bhansali A., Shah V.N., Rao D.S. Singapore Med J 52:890-893(2011) · Mapped (8) |
| NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Zhao J.L., Rao D.S., Boldin M.P., Taganov K.D., O'Connell R.M., Baltimore D. Proc. Natl. Acad. Sci. U.S.A. 108:9184-9189(2011) · Mapped (3) |
| MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. O'Connell R.M., Chaudhuri A.A., Rao D.S., Gibson W.S., Balazs A.B., Baltimore D. Proc. Natl. Acad. Sci. U.S.A. 107:14235-14240(2010) · Mapped (44) |
| FGF-2 stimulation of RANK ligand expression in Paget's disease of bone. Sundaram K., Senn J., Yuvaraj S., Rao D.S., Reddy S.V. Mol. Endocrinol. 23:1445-1454(2009) · Mapped (5) |
| Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity. Shanmugarajan S., Youssef R.F., Pati P., Ries W.L., Rao D.S., Reddy S.V. J. Cell. Biochem. 104:1500-1508(2008) · Mapped (12) |
| Cloning of rhesus monkey LILRs. Slukvin I.I., Grendell R.L., Rao D.S., Hughes A.L., Golos T.G. Tissue Antigens 67:331-337(2006) · UniProtKB (8) |
| Elevated serum kininogen in patients with Paget's disease of bone: a role in marrow stromal/preosteoblast cell proliferation. Tsuruga E., Rao D.S., Baatz J.E., Reddy S.V. J. Cell. Biochem. 98:1681-1688(2006) · Mapped (10) |
| Huntingtin interacting protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts. Oravecz-Wilson K.I., Kiel M.J., Li L., Rao D.S., Saint-Dic D., Kumar P.D., Provot M.M., Hankenson K.D., Reddy V.N., Lieberman A.P. et al. Hum. Mol. Genet. 13:851-867(2004) · UniProtKB (1) · Mapped (2) |
| HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains. Hyun T.S., Rao D.S., Saint-Dic D., Michael L.E., Kumar P.D., Bradley S.V., Mizukami I.F., Oravecz-Wilson K.I., Ross T.S. J. Biol. Chem. 279:14294-14306(2004) · UniProtKB (2) · Mapped (9) |
| Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells. Rao D.S., Bradley S.V., Kumar P.D., Hyun T.S., Saint-Dic D., Oravecz-Wilson K., Kleer C.G., Ross T.S. Cancer Cell 3:471-482(2003) · Mapped (3) |
| Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. Rao D.S., Hyun T.S., Kumar P.D., Mizukami I.F., Rubin M.A., Lucas P.C., Sanda M.G., Ross T.S. J. Clin. Invest. 110:351-360(2002) · UniProtKB (1) · Mapped (4) |
| Huntingtin interacting protein 1 is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors. Rao D.S., Chang J.C., Kumar P.D., Mizukami I., Smithson G.M., Bradley S.V., Parlow A.F., Ross T.S. Mol. Cell. Biol. 21:7796-7806(2001) · UniProtKB (2) · Mapped (2) |